Background-Obesity increases the risk of cardiovascular disease, hypertension, diabetes, digestive diseases, and some cancers. Several studies have shown that excess weight or weight gain is related to pulmonary dysfunction, but this issue needs to be further clarified. Methods-The analysis was based on data of the Humboldt cohort study which was conducted in the town of Humboldt, Saskatchewan, Canada. The baseline survey in 1977 included 1202 adults, comprising 94% of all residents aged 25-59 years. Of these, 709 (59%) were followed up in 1983. Pulmonary function (forced vital capacity (FVC), forced expiratory volume in one second (FEVy) and maximal mid expiratory flow rate (MMFR)) and weight were measured in both surveys. Weight gain was determined by subtracting weight at baseline from weight at follow up. A residual analysis was used to examine the relationship between body mass index (BMI) at baseline, weight gain, and pulmonary function decline. Results-Both BMI at baseline and weight gain were significantly related to pulmonary function at follow up. The effect of weight gain during the study period, however, was more prominent. The results showed that both mean residual FVC and FEV, were highest in the group that gained <10 kg, lowest in the group that gained > 4.0 kg, and intermediate in the group that gained 1-03-9 kg in both men and women after taking age, BMI at baseline, and smoking into account. The effect of weight gain on pulmonary function was greater in men than in women. Multiple regression analysis showed that each kilogram of weight gain was associated with an excess loss of 26 ml in FVC and 23 ml in FEV, in men, and 14 ml and 9 ml respectively in women.
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Conclusions-Weight gain is significantly related to lung dysfunction. The effect of weight gain on pulmonary function is greater in men than in women.
(Thorax 1993;48:375-380)
The relationship between obesity or excess weight and health and longevity has been receiving increasing attention.' 2 Numerous epidemiological studies have shown that obesity might increase the risk of cardiovascular disease, hypertension, diabetes, and cancer, as well as other diseases including arthritis, gout, kidney stones, and gallbladder disease.' A number of clinical studies3-"3 have described the effects of obesity on lung function test variables including functional residual capacity and expiratory reserve volume; however, the studies on the relationship between obesity and airways function have given inconsistent results.
Body weight and weight gain as risk factors for pulmonary dysfunction have not been well documented by population based studies. In a cross sectional study of data from 3046 children and adults (seven years and over), Schoenberg et aP4 found that pulmonary function initially increased as weight increased and then decreased as weight continued to increase. They considered that the increase of pulmonary function with weight may reflect increasing muscle force, and the decrease with further weight gain may be due to obesity which limits the mobility of the thoracic cage. 14 Secondly, analysis of covariance and multiple regression analysis24 were used to examine the relationships between the residual (r) pulmonary function measurements (including rFVC, rFEV,, and rMMFR) and BMI at baseline and weight gain, after adjustment for confounding factors in men and women separately. One reason for using residual analysis is that it excludes past effects of weight change and other factors such as smoking and previous occupational exposures on pulmonary function decline during the study period. In addition, the variance of pulmonary function measurements at follow up was larger than at baseline. This approach was not influenced by this difference.
Results Table 1 shows the mean values of age, height, weight, and BMI at baseline. The women were, on average, one year older than the men, but this was not significant (F = 1 984, p = 0-160). Mean BMI in men was significantly higher than in women, 27-5 kg/iM2 v 25-5 kg/M2 (F= 35 616, p < 0 001).
Mean rFVC, rFEVI, and rMMFR stratified by gender and BMI at baseline are given in table 2. The crude mean values of rFVC and rFEV, in the <24 kg/M2 group appear to be higher than those in the 24-0-27-9 and > 28-0 kg/iM2 groups in both men and women. Smoking, a most important risk factor of lung dysfunction, is also related to body weight. In this study the mean BMI at baseline was highest in ex-smokers, lowest in smokers, and intermediate in non-smokers (unpublished data). After adjustment for the covariates including age, weight gain, and smoking state by analysis of covariance, there were significant differences in rFVC and rFEV, between BMI groups in men (table 2) . The rFEV, in men decreased significantly with increasing mean value of BMI at baseline. The adjusted mean rFVC in men was highest in the <24 kg/M2 group; however, the mean value was slightly higher in the 28-0 kg/M2 group than in the 24{0-27-9 kg/M2 group, although they were very close. In women, both adjusted mean rFVC and rFEV, were decreased with increasing BMI at baseline, but did not reach significance at a = 0 05 (table 2). Figure 1 illustrates the relationships between rFVC and rFEV, and the value of baseline BMI in men and women after taking the covariates into account. BMI-body mass index.
Body weight and weight gain related to pulmonary function decline in adults: a six year follow up study Table 2 Mean (SD) residual pulmonary function test variables by BMI at baseline and gender, crude and adjustedfor age, weight gain and smoking (analysis of covariance) rFVC (7) rFE VI (7) rMMFR ( The data show that weight gain was an important predictor of decline of FVC and FEV1 in both men and women. Average weight gain over the six year period was less in men than in women, 1-3 (SD 4 8) kg v 2-7 (SD 6-4) kg (F = 10-175, p = 0-002). The subjects were classified into three groups according to weight gain from 1977 to 1983 (<1P0 kg, 1P0-3 9 kg, and )4O0 kg). Table 3 shows that both mean rFVC and rFEV, were highest in the <1 0 kg group and lowest in the <24-0 24-0-27-9 28 fig 2) . The difference in the adjusted mean rFVC between the <1 0 kg group and the >4-0 kg rFVC (7) rFE V, (7) rMMFR ( Weight gain (kg) Weight gain (kg) Table 4 Multiple regression analysis of relationship between residual pulmonaryfunction and weight gain and BMI change adjustedfor age, BMI at baseline, and smoking.
Weight gain (kg)
BMI change (kg/m2) rFVC(I) rFE V, (7) rMMFR(lls) rFVC (7) rFE VI (7) rMMFR(lls) group was 245 ml in men and 106 ml in women. The difference in the adjusted mean rFEV, between the two groups was 229 ml in men and 98 ml in women. Multiple regression analysis shows that weight gain was significantly related to decline of FVC, FEV1, and MMFR in men and to FVC and FEV1 in women after taking age, BMI at baseline, and smoking into account (table 4) . Each kilogram of weight gain from 1977 to 1983 was associated with an average excess loss of 26 ml in FVC, 23 ml in FEV1 and 24 ml/s in MMFR in men. In women, the excess losses were 14 ml in FVC and 9 ml in FEV1. Weight gain (kg) We used interaction of weight gain with gender to assess whether the gender difference in the relationship between weight gain and pulmonary function was significant. Table 5 shows the results of significance tests after adjustment for age, smoking, and BMI at baseline. The interaction term of weight gain with gender was significantly related to FVC (t = 2-782, p = 0006) and FEV, (t = 3 543, p < 0-001), suggesting that the relationship between weight gain and pulmonary function was stronger in men than in women.
Discussion
This study shows that BMI at baseline and subsequent weight gain were significantly related to decline of pulmonary function tests in adults. Compared with BMI at baseline, weight gain was a more prominent predictor of pulmonary function decline, and was significantly related to decline of FVC, FEVI, and MMFR in men and to decline of FVC and FEVy in women during the six year follow up period. The unit effect of weight gain was larger in men than in women although women gained more weight than men during the study period.
We were aware of, and attempted to adjust for, a number of potential confounding variables that might relate to the effects of body weight on pulmonary function. 25 The analysis was carried out to detect changes in pulmonary function test variables related to weight gain over a six year period (from 1977 to 1983). It was necessary to control for confounding effects before and during the six years. Stagewise analysis was used to adjust the confounding effects in two stages. Firstly, we used the "residual" analysis technique to remove the effects of body weight and confounding factors that occurred before the study period. We found, for example, that total smoking (pack years) before 1977 was not related to the residual pulmonary function measurements. This type of "residual" analysis also removed the effects of initial pulmonary function measurements on final measurements. Secondly, we used multiple regression analysis to determine the effect of weight gain on the residual pulmonary function measurements after adjustment for the effects of potential confounding factors that occurred during the study period. The effect of weight gain on decline of pulmonary function was found to be independent of smoking and was not confounded by a history of cardiopulmonary disease.
Previous studies have suggested that pulmonary function was decreased at both extremes of weight.'1-6 In a study of 7123 male air military personnel (3149 under 20 years of age) by Bande and coworkers,'5 both cross sectional and longitudinal analyses showed a similar relationship between weight and pulmonary function in non-smokers; in smokers, this effect was less pronounced. Dockery and coworkers'6 reported lower lung function than expected in subjects weighing more than 15 kg above or below the expected mean weight for their height and gender in a study of 2454 non-smoking adults aged 25-74 years in six American cities. In contrast to our study, these results were mainly obtained from non-smoking healthy'4-'6 or younger '4' 15 populations. If the initial increase in pulmonary function with increasing weight is considered a "muscularity effect" and the decrease with further increasing weight an "obesity effect",'4 weight in our population, which ranged from 25 to 59 years and included both healthy and "unhealthy" subjects, would have more "obesity effect" than "muscularity effect." In addition, weight is closely correlated with body size and BMI is an indicator of obesity. Our results showing decreasing residuals of pulmonary function with increasing BMI at baseline are not in conflict with the results of these studies.
Weight gain related to decline of FVC has been documented in previous studies. In a longitudinal study of 592 men aged 25-74 years living in a rural unpolluted area, Dontas and colleagues'8 found that in the subjects with BMI ) 21 kg/M2 at baseline, the greater the increase of the BMI at the 10 year follow up, the greater the loss of FVC. The change in BMI, however, was not found to 20 They suggested that impaired pulmonary function might cause the affected smokers to lose weight, or reflect the effect of cigarette smoking on both the respiratory tract and metabolism. The subjects in their study, however, represent a particular group of steelworkers rather than a general population. Other studies show no significant relationship between obesity and airways function.'22628 The reasons for this controversy could include methodological limitations, particularly in sample selection, sample size, and confounder controlling, and may have contributed to the apparent lack of significance in the relationship between obesity and airways function. '3 Our data show that weight gain was linearly related to decline of lung function test variables (FVC, FEV,, and MMFR in men and FVC and FEV, in women). BMI is frequently used as a surrogate measure for obesity in epidemiological studies. In this longitudinal analysis, height was almost constant during the study period and BMI change from 1977 to 1983 showed a similar relationship to pulmonary function decline. There was no evidence in our study of any apparent threshold in decline of pulmonary function with increasing weight gain. The risk was continuously distributed.
The effect of weight gain on pulmonary function decline was larger in men than in women. These findings were consistent with those reported by Rubinstein and coworkers'3 who found that obese men had reduced forced expiratory flow rates at low lung volumes, whereas obese women did not.
The progressive reduction in expired flow rates with increasing age, as reflected by FEV1, has been thought to be related to progressive loss of the elastic recoil properties of the lung with age.29 When longitudinal studies of lung function became available, there appeared to be a more modest loss of lung function with age30 leading to speculation that apparent losses from cross sectional studies could reflect intergenerational differences. Our study indicates that weight gain may be a determinant of loss of lung function. These findings suggest that the influence of weight gain on decline of pulmonary function is independent of the possible effect of loss of elastic recoil with increasing age.
Whatever the aetiology, weight gain is likely to be a significant risk factor in its decline of pulmonary function in adults. These findings raise the possibility that weight gain may be one of the principal determinants of reduction in lung function, and that the relationship may be modified by gender. 
